A detailed history of Nicholas Company, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Nicholas Company, Inc. holds 736,725 shares of BSX stock, worth $64.9 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
736,725
Previous 900,625 18.2%
Holding current value
$64.9 Million
Previous $69.4 Million 10.99%
% of portfolio
1.05%
Previous 1.18%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$72.96 - $84.0 $12 Million - $13.8 Million
-163,900 Reduced 18.2%
736,725 $61.7 Million
Q2 2024

Jul 24, 2024

SELL
$67.33 - $77.71 $14.4 Million - $16.7 Million
-214,345 Reduced 19.22%
900,625 $69.4 Million
Q3 2023

Feb 13, 2024

BUY
$50.19 - $54.68 $15,057 - $16,404
300 Added 0.03%
1,114,970 $58.9 Million
Q3 2023

Nov 13, 2023

BUY
$50.19 - $54.68 $15,057 - $16,404
300 Added 0.03%
1,114,970 $58.9 Million
Q4 2022

Feb 13, 2024

SELL
$39.56 - $47.22 $9,890 - $11,805
-250 Reduced 0.02%
1,114,670 $51.6 Million
Q4 2022

Feb 09, 2023

SELL
$39.56 - $47.22 $9,890 - $11,805
-250 Reduced 0.02%
1,114,670 $51.6 Million
Q2 2022

Feb 13, 2024

SELL
$35.24 - $47.1 $21,672 - $28,966
-615 Reduced 0.06%
1,114,920 $41.6 Million
Q2 2022

Jul 26, 2022

SELL
$35.24 - $47.1 $21,672 - $28,966
-615 Reduced 0.06%
1,114,920 $41.6 Million
Q1 2022

Feb 13, 2024

BUY
$40.9 - $45.1 $23,108 - $25,481
565 Added 0.05%
1,115,535 $49.4 Million
Q1 2022

May 11, 2022

SELL
$40.9 - $45.1 $274,643 - $302,846
-6,715 Reduced 0.6%
1,115,535 $49.4 Million
Q4 2021

Feb 11, 2022

BUY
$38.07 - $44.87 $10,278 - $12,114
270 Added 0.02%
1,122,250 $47.7 Million
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $2,886 - $3,211
-70 Reduced 0.01%
1,121,980 $48.7 Million
Q1 2021

May 14, 2021

BUY
$35.27 - $39.67 $2 Million - $2.25 Million
56,655 Added 5.32%
1,122,050 $43.4 Million
Q4 2020

Feb 10, 2021

BUY
$33.15 - $41.97 $3.23 Million - $4.09 Million
97,410 Added 10.06%
1,065,395 $38.3 Million
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $10,332 - $12,668
-300 Reduced 0.03%
967,985 $37 Million
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $6,188 - $8,017
205 Added 0.02%
968,285 $34 Million
Q1 2020

May 13, 2020

BUY
$25.83 - $45.71 $779,936 - $1.38 Million
30,195 Added 3.22%
968,080 $31.6 Million
Q4 2019

Feb 13, 2020

BUY
$37.87 - $45.37 $2,461 - $2,949
65 Added 0.01%
937,885 $42.4 Million
Q2 2019

Aug 13, 2019

SELL
$34.91 - $42.98 $5,236 - $6,446
-150 Reduced 0.02%
937,820 $40.3 Million
Q1 2019

May 14, 2019

SELL
$32.91 - $40.75 $260,647 - $322,740
-7,920 Reduced 0.84%
937,970 $36 Million
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $2,626 - $3,090
-80 Reduced 0.01%
945,890 $36.4 Million
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $2.71 Million - $3.47 Million
100,995 Added 11.95%
945,970 $30.9 Million
Q1 2018

May 14, 2018

BUY
$25.2 - $28.54 $21.3 Million - $24.1 Million
844,975 New
844,975 $23.1 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $126B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Nicholas Company, Inc. Portfolio

Follow Nicholas Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.